No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Healthcare Information Services
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
www.promed.com.auNo one on the platform currently holds PME.AX.
No tracked institution reports a position in PME.AX as of their last filing.
No one on the platform has traded PME.AX yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 44.9% | 93.2% | 95.4% | — | — | — |
| Rev. Growth % | 22.9% | 31.0% | ||||
| Profit Margin % | 101.4% | 60.6% | 48.4% | |||
| Free Cash Flow Margin % | 52.0% | 50.8% | 47.5% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $339M | +30.2% | $1.82 | $1.71–$1.87 | — | 12 |
| 2028 | $420M | +23.9% | $2.29 | $1.99–$2.44 | — | 12 |
| 2029 | $510M | +21.6% | $2.82 | $2.26–$3.14 | — | 11 |
| 2030 | $632M | +23.8% | $3.87 | $3.34–$4.23 | — | 7 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-17 | $0.67 | $0.71 | +5.9% |
| 2026-02-11 | $0.66 | $1.64 | +148.1% |
| 2025-08-13 | $0.59 | $0.61 | +4.4% |
| 2025-02-14 | $0.48 | $0.48 | +0.6% |
| 2024-08-15 | $0.41 | $0.45 | +8.6% |
| 2024-02-15 | $0.36 | $0.35 | -4.7% |
| 2023-08-16 | $0.31 | $0.32 | +4.2% |
| 2023-02-16 | $0.25 |
| $0.26 |
| +4.7% |
| $3M |
| — |
| FPH.AXFisher & Paykel Healthcare Corporation Limited | $35.14 | -0.17% | $20.6B | — |
| GLH.AXGlobal Health Limited | $0.05 | +0.00% | $3M | — |
Source: Financial Modeling Prep · peers by sector/industry